Journey Medical earnings were -$6.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest DERM earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$312.0k, down 86% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DERM reported annual earnings of -$11.4M, with -22.1% growth.
What were Journey Medical's earnings last quarter?
On DERM's earnings call on Aug 12, 2026, Journey Medical (NASDAQ: DERM) reported Q2 2026 earnings per share (EPS) of -$0.01, up 93.75% year over year. Total DERM earnings for the quarter were -$312.00 thousand. In the same quarter last year, Journey Medical's earnings per share (EPS) was -$0.16.
As of the last Journey Medical earnings report, Journey Medical is currently losing money. Journey Medical's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$6.10 million, a 30.14% decrease year over year.
What was DERM's earnings growth in the past year?
As of Journey Medical's earnings date in Aug 12, 2026, Journey Medical's earnings has grown year over year. DERM earnings in the past year totalled -$6.10 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.